Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.730
-0.090 (-3.19%)
At close: Dec 24, 2025
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €207.14 million as of December 26, 2025. Its market cap has decreased by -12.01% in one year.
Market Cap
207.14M
Enterprise Value
443.70M
Revenue
226.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.73
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 207.14M, an increase of 1,060.75%. That is a compound annual growth rate of 29.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 207.14M | -19.06% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | 298.55M | 163.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.68B |
| Laboratorios Farmaceuticos Rovi | 3.21B |
| Almirall | 2.75B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 763.78M |
| Oryzon Genomics | 250.75M |
| Prim, S.A. | 224.61M |